The median OS of HCC patients with EpCAM+ CTCs was shorter than patients without CTCs (median months [95% CI]: 15.3 [2.3–28.3] vs. 24.9 [19.1–30.6], p = 0.017), n = 59 [20]. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.